β-受体阻断剂是六十年代开始发展起来的一种心血管药物,其应用范围正日益扩大,不论从疗效上以及其药理学的理论上均受到注意。近十五年来,国外发表了数以千计的文献,记录了世界各国的大量临床经验,已有多篇文献和专著进行过综述。国内临床也开始应用。现仅就近年推荐使用的一些β-受体阻断剂综合加以介绍,供参考。β-受体阻断剂一词起源于1948年,Ahlquist将肾上腺素能受体按其对一系列儿茶酚胺 Beta-blockers are a kind of cardiovascular medicine that began to develop in the 1960s. Its application scope is expanding day by day, and it is paid attention not only in terms of curative effect and theory of pharmacology. In the recent fifteen years, thousands of documents have been published in foreign countries, which have recorded a great deal of clinical experience in various countries in the world. They have been reviewed in many documents and monographs. Domestic clinical application also began. Is only recommended in recent years, some β-blockers synthesized to be introduced for reference. The term “beta-blocker” originated in 1948 and Ahlquist treated adrenergic receptors with a series of catecholamines